Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 6/5/2008 First Published: 4/23/2004


1.		Phase III Randomized Study of Single-Dose Local Radiotherapy Versus Ibandronate in Patients With Localized Metastatic Bone Pain

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				Over 18				Other				CRUK-NCRI-RT-02-01 EU-20224, RIB, ISRCTN86185157, NCT00082927

Last Modified: 1/14/2009 First Published: 7/23/2005


2.		Phase III Randomized Study of Adjuvant Zoledronate Versus Clodronate Versus Ibandronate in Women With Resected Primary Stage I-III Adenocarcinoma of the Breast

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				SWOG-S0307 NCCTG-SWOG-S0307, ECOG-SWOG-S0307, NSABP-SWOG-S0307, CALGB-SWOG-S0307, CAN-NCIC-SWOG-S0307, S0307, NCT00127205


3.		Study in Elderly Patients With Early Breast Cancer (ICE)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				65 and over				Other				GBG32 BIG 4-04, NCT00196859


4.		A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-Positive Primary Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 64				Other				GBG 33 GAIN, NCT00196872

Last Modified: 11/12/2007 First Published: 5/11/2006


5.		Phase III Randomized Study of Ibandronate Versus Zoledronate in Patients With Newly Diagnosed Bone Metastases Secondary to Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Over 18				Other, Pharmaceutical / Industry				WCTU-ZICE NCRI-ZICE, ROCHE-ZICE, ISRCTN13914201, EU-20613, EUDRACT-2005-001710-40, NCT00326820


6.		Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				Not specified				Other				ML20115 EudraCT: 2006-000697-74, NCT00381368


7.		A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				18 and over				Pharmaceutical / Industry				ML20684 NCT00502736

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute